The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis.

Sub-cellular biochemistry

Volumn 28, Issue , 1997, Pages 117-144

  Tint, G S ^a   Batta, A K ^a   Xu, G ^a   Shefer, S ^a   Honda, A ^a   Irons, M ^a   Elias, E R ^a   Salen, G ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [2 [1 (4 CHLOROCINNAMYL) 4 PIPERAZINYL]ETHYL]BENZOIC ACID; 7 DEHYDROCHOLESTEROL; 7 DEHYDROCHOLESTEROL REDUCTASE; 7-DEHYDROCHOLESTEROL; 7-DEHYDROCHOLESTEROL REDUCTASE; CHOLESTA 5,8 DIEN 3 BETA OL; CHOLESTA-5,8-DIEN-3 BETA-OL; CHOLESTEROL; ENZYME INHIBITOR; OXIDOREDUCTASE; PIPERAZINE DERIVATIVE;

ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; LIVER; METABOLISM; REVIEW; SMITH LEMLI OPITZ SYNDROME;

ANIMALS; CHOLESTADIENOLS; CHOLESTEROL; DEHYDROCHOLESTEROLS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; HUMANS; LIVER; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PIPERAZINES; SMITH-LEMLI-OPITZ SYNDROME;

MLCS; MLOWN;

EID: 0030629333     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-5901-6_5     Document Type: Review

References (135)